18-657352-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000701410.1(TYMSOS):​n.245A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 173,424 control chromosomes in the GnomAD database, including 40,665 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 34942 hom., cov: 31)
Exomes 𝑓: 0.73 ( 5723 hom. )

Consequence

TYMSOS
ENST00000701410.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.883

Publications

30 publications found
Variant links:
Genes affected
TYMSOS (HGNC:29553): (TYMS opposite strand RNA)
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.714 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000701410.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
NR_171001.1
n.450+490A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
ENST00000323813.6
TSL:1
n.511+490A>G
intron
N/A
TYMSOS
ENST00000701410.1
n.245A>G
non_coding_transcript_exon
Exon 1 of 2
TYMSOS
ENST00000585033.1
TSL:2
n.428+490A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
102856
AN:
151908
Hom.:
34908
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.631
Gnomad AMI
AF:
0.790
Gnomad AMR
AF:
0.726
Gnomad ASJ
AF:
0.694
Gnomad EAS
AF:
0.474
Gnomad SAS
AF:
0.635
Gnomad FIN
AF:
0.731
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.702
Gnomad OTH
AF:
0.676
GnomAD4 exome
AF:
0.729
AC:
15596
AN:
21396
Hom.:
5723
AF XY:
0.730
AC XY:
7923
AN XY:
10848
show subpopulations
African (AFR)
AF:
0.659
AC:
511
AN:
776
American (AMR)
AF:
0.759
AC:
419
AN:
552
Ashkenazi Jewish (ASJ)
AF:
0.757
AC:
689
AN:
910
East Asian (EAS)
AF:
0.509
AC:
510
AN:
1002
South Asian (SAS)
AF:
0.741
AC:
160
AN:
216
European-Finnish (FIN)
AF:
0.780
AC:
1367
AN:
1752
Middle Eastern (MID)
AF:
0.725
AC:
87
AN:
120
European-Non Finnish (NFE)
AF:
0.739
AC:
10761
AN:
14564
Other (OTH)
AF:
0.726
AC:
1092
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
208
416
624
832
1040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.677
AC:
102945
AN:
152028
Hom.:
34942
Cov.:
31
AF XY:
0.679
AC XY:
50431
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.631
AC:
26168
AN:
41450
American (AMR)
AF:
0.726
AC:
11093
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.694
AC:
2408
AN:
3472
East Asian (EAS)
AF:
0.475
AC:
2443
AN:
5148
South Asian (SAS)
AF:
0.635
AC:
3059
AN:
4820
European-Finnish (FIN)
AF:
0.731
AC:
7734
AN:
10576
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.702
AC:
47717
AN:
67960
Other (OTH)
AF:
0.671
AC:
1418
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1722
3444
5165
6887
8609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.687
Hom.:
126463
Bravo
AF:
0.673
Asia WGS
AF:
0.544
AC:
1891
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.0
DANN
Benign
0.59
PhyloP100
0.88
PromoterAI
0.016
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2853741; hg19: chr18-657352; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.